Top Peptide Therapeutics Companies in United Arab Emirates

The company specializes in niche therapeutics for rare diseases and specialty care, offering tailored market access solutions in the MENAT region. They connect innovative global biotech companies with local healthcare providers to ensure timely access to treatments, which may be relevant for peptide therapeutics targeting rare diseases.

Wellpharma Medical Solutions (WMS) specializes in the production of therapeutic products, including intravenous (IV) fluids and injectables, which are essential for targeted relief in medical care. Their commitment to cGMP standards and quality management ensures that they meet the growing demand for safe and effective therapeutic solutions in the UAE and beyond.

The company, Biotech Pharma, focuses on providing quality pharmaceutical products, including those in specialized fields like oncology and autoimmune disorders. With over a decade of experience in product development and marketing, they emphasize a robust supply chain and exceptional product quality, which may be relevant for those interested in peptide therapeutics.

The company, Bravo Pharma, is dedicated to revolutionizing personal health and medical research, with a focus on innovative solutions in digital health and personalized medicine. Their commitment to quality and ethical healthcare aligns with advancements in medical technologies that could enhance the future of health and longevity.

Biologix specializes in bringing innovative drugs to the MENA region, with a focus on rare disease management and treatment accessibility.

NewBridge Pharmaceuticals specializes in in-licensing and commercializing innovative therapeutics, including those that may involve peptide therapeutics, to address unmet medical needs in the MENA region. Their focus on bridging access gaps with FDA or EMA approved therapies highlights their commitment to bringing advanced medical solutions to the market.

YSD International specializes in pharmaceutical export services, which may include peptide therapeutics within their high-quality product offerings. Their commitment to innovative solutions and regulatory support suggests a focus on advanced therapeutic approaches.

Hayat Biotech is focused on delivering innovative biotechnological solutions, including biologics and biosimilars. Their commitment to advancing life sciences positions them as a key player in the therapeutic landscape.

Vieco Pharmaceuticals, founded in 2014, focuses on providing high-quality medicines and employs the latest pharmaceutical production technologies. Their commitment to scientific excellence and adherence to international standards positions them as a key player in the pharmaceutical industry.

Lunatus serves as a vital connection between international healthcare companies and the Arabian Gulf and Middle East markets, facilitating the journey of products from concept to customer. They manage all registration procedures, ensuring compliance with local authorities, which is essential for the successful introduction of new therapies, including peptide therapeutics.